Radiotherapy

Radioterapia

Radiotherapy mainly uses very high-energy ionising radiation to destroy tumour cells by preventing their rapid division. Healthy tissue near the tumour may also be affected by the treatment, but unlike tumour cells, it has the ability to repair the damage caused by the treatment within a few weeks of its completion. Minimising the dose received by healthy tissue is a primary objective of any radiotherapy treatment. This dose reduction can be achieved using high-precision techniques such as intensity modulation (IMRT), image-guided radiotherapy (IGRT), or respiratory motion control and synchronisation techniques (gating), RapidARC. The Radiation Oncology Department at the Teknon Cancer Institute is a pioneer in the application of these technologies. The recent acquisition of the True-Beam STX treatment unit with the Calypso system allows us to remain at the forefront of radiotherapy and continue offering our patients advanced, state-of-the-art treatments while maintaining excellent disease control results and minimal toxicity. The True-Beam STX treatment unit is equipped with, among other features, a ‘PerfectPitch’ robotic table with 6 degrees of freedom that allows for automated treatment administration.

HDMLC120 multi-leaf collimator with 2.5 mm leaves that allows for highly complex and high-resolution treatments such as radiosurgery, arteriovenous malformations, and fractionated stereotactic therapies.

It incorporates a robotic image control system, 4D CBCT, which provides image acquisition capabilities for patient positioning at the time of treatment administration and analysis of tumour movement and volume changes (adaptive radiotherapy).

Advanced respiratory movement management system (Gating) that enables monitoring and synchronisation of respiratory movement with treatment administration.

CALYPSO transponder tracking system: It is a real-time tumour localisation and tracking system that provides continuous information on their location and streamlines monitoring during treatment administration. The system is based on the detection of Beacon© electromagnetic signals using GPS for the body technology. It detects small movements of the tumour to keep it in the path of the radiation beam, which facilitates successful treatment and reduces potential side effects.